↓ Skip to main content

Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering

Overview of attention for article published in Frontiers in oncology, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
45 Mendeley